Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp

Comparison of the ATB® Fungus 2 with the AFST-EUCAST for in vitro susceptibility testing of Candida spp

The increase of diseases caused by Candida spp., and the treatment failures, has underscored the need for testing the susceptibilities to antifungal agents. The commercial panel ATB® Fungus 2 was compared with the reference testing method of the European Subcommittee on Antifungal Susceptibility Tes...

Full description

Bibliographic Details
Main Authors:	Jehidys Estella Montiel Ramos, Andrea Corrales Bernal, María Paulina Vélez Bravo, Armando Baena Zapata, Ana Cecilia Mesa Arango
Format:	Article
Language:	English
Published:	Publicaciones UIS 2014-04-01
Series:	Salud UIS
Subjects:	antifungal susceptibility Candida spp ATB® Fungus 2 AFST-EUCAST susceptibilidad antifúngica
Online Access:	http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072014000100002&lng=en&tlng=en

Similar Items

Antifungal susceptibility testing for yeasts: how, when and why, according to the new EUCAST guidelines
by: Esther Manso, et al.
Published: (2011-03-01)

Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal
by: Marcos Aurélio Stoppa, et al.
Published: (2009-01-01)

A Study on Prevalence and Characterization of Candida Species in Immunocompromised Patients
by: Dhanapal Nandini, et al.
Published: (2021-12-01)

In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
by: Patrick Schwarz, et al.
Published: (2022-04-01)

Estudio comparativo de medición entre lecturas visuales y espectrofotométricas en pruebas de susceptibilidad in vitro de aislamientos de candida Comparative study of measure visual and spectrophotometer lectures in a in vitro antifungal susceptibility testing in candida isolates
by: Luis Enrique Jerez Puebla, et al.
Published: (2011-06-01)

Comparison between EUCAST Broth Microdilution and MIC Strip Test in Defining Isavuconazole In Vitro Susceptibility against <i>Candida</i> and Rare Yeast Clinical Isolates
by: Maddalena Calvo, et al.
Published: (2023-01-01)

The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing
by: Roya Vahedi-Shahandashti, et al.
Published: (2023-09-01)

EUCAST v.12.0 Review Focused on Changes
by: Sae Am Song
Published: (2022-09-01)

Design of mixture experiments for the analysis of viscosity behavior of sulfonated polyacrylamide solutions (ATBS) with changes in salinity, hardness, and polymer concentration.
by: Julia Herrera, et al.
Published: (2022-04-01)

Changes in the interpretation of the results of susceptibility testing of fungi
by: Rok Tomazin, et al.
Published: (2014-05-01)

A New High-Throughput-Screening-Assay for Photoantimicrobials Based on EUCAST Revealed Unknown Photoantimicrobials in Cortinariaceae
by: Johannes Fiala, et al.
Published: (2021-08-01)

The diagnostic value and pathogenetic role of lncRNA-ATB in patients with osteoarthritis
by: Xiliang Dang, et al.
Published: (2018-11-01)

Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against <i>Candida glabrata</i>
by: Petra V. Schwarz, et al.
Published: (2022-05-01)

In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study
by: Guillermo Quindós, et al.
Published: (2022-05-01)

Susceptibility Testing of Fungi to Antifungal Drugs
by: Maurizio Sanguinetti, et al.
Published: (2018-09-01)

Pefloxacin as a Surrogate Marker for Fluoroquinolone Susceptibility for Salmonella typhi: Problems and Prospects
by: Balaji Veeraraghavan, et al.
Published: (2016-08-01)

Distribution of Clinical Staphylococccus aureus Isolates and Antibiotic Resistance Profile: Three-Year Data
by: Muradiye Yarar, et al.
Published: (2022-11-01)

Antifungal susceptibility testing of Candida in the Clinical Laboratory: how to do it, when to do it, and how to interpret it
by: Esther Manso, et al.
Published: (2014-06-01)

Rapid antimicrobial susceptibility of Enterobacteriaceae by disk diffusion directly from blood culture bottles using the EUCAST RAST breakpoints
by: Amanda Martins, et al.
Published: (2020-09-01)

Rastreio da atividade anti-candida por bactérias do ácido láctico em amostras de saliva de indivíduos saudáveis
by: Greta Aguilera, et al.
Published: (2022-04-01)

LncRNA-ATB inhibits human keloid fibroblast proliferation and collagen synthesis
by: LYU Xiong, QIU Ling-jiang, LAO Xun-ji, TAN Wei-qiang
Published: (2022-10-01)

Treatment of chronic relapsing urinary tract infection with antibiotics selected by AtbFinder
by: George V. Tetz, et al.
Published: (2023-01-01)

PERAN PEMEDIASI ATTITUDE BECOMING SOCIAL ENTREPRENEUR (ATB) PADA PENGARUH ANTARA EMPATI TERHADAP MINAT BERWIRAUSAHA SOSIAL
by: Purbo Jadmiko
Published: (2019-10-01)

The Function and Mechanism of Long Non-coding RNA-ATB in Cancers
by: Huizhong Xiao, et al.
Published: (2018-04-01)

Comparison of Two Commercial Colorimetric Broth Microdilution Tests for <i>Candida</i> Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM
by: Sophie Philips, et al.
Published: (2021-05-01)

Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer
by: Elena De Carolis, et al.
Published: (2021-03-01)

ATBS1-INTERACTING FACTOR 2 Negatively Modulates Pollen Production and Seed Formation in Arabidopsis
by: Yoon Kim, et al.
Published: (2021-07-01)

Exosomal lncRNA ATB Derived from Ovarian Cancer Cells Promotes Angiogenesis via Regulating miR-204-3p/TGFβR2 Axis
by: Yuan D, et al.
Published: (2022-01-01)

Usefulness of Microscan System panels with EUCAST clinical breakpoints to evaluate the antimicrobial susceptibility of ß-lactamase producing- Gram negative isolates
by: Elisabetta Nucleo, et al.
Published: (2011-12-01)

Updated EUCAST Clinical Breakpoints against <i>Aspergillus</i>, Implications for the Clinical Microbiology Laboratory
by: Jesús Guinea
Published: (2020-12-01)

The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus
by: Jonas Van Dingenen, et al.
Published: (2019-02-01)

Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital
by: Aline Munting, et al.
Published: (2022-12-01)

AtbZIP62 Acts as a Transcription Repressor to Positively Regulate ABA Responses in Arabidopsis
by: Saddam Hussain, et al.
Published: (2022-11-01)

Influence of physicochemical variables on polymer adsorption in porous media
by: Julia Herrera-Quintero, et al.
Published: (2022-03-01)

Antibiotic Susceptibility Pattern and Bacterial Spectrum Among Patients with External Eye Infections at Menelik II Referral Hospital in Addis Ababa, Ethiopia [Response to Letter]
by: Woreta AN, et al.
Published: (2022-04-01)

Implementing the Updated Guidelines in Routine Clinical Microbiology Reporting [Letter]
by: Pathak KN, et al.
Published: (2022-04-01)

Resetting amino acid metabolism of cancer cells by ATB0,+-targeted nanoparticles for enhanced anticancer therapy
by: Longfa Kou, et al.
Published: (2022-03-01)

Gene Expression Analysis of Two Epithelial-mesenchymal Transition-related Genes: Long Noncoding RNA-ATB and SETD8 in Gastric Cancer Tissues
by: Nooshin Nourbakhsh, et al.
Published: (2018-01-01)

Acute obstructive fungus ball pyelonephritis with Candida parapsilosis: A case report
by: Rajo Païdia Radinasoa, et al.
Published: (2023-06-01)

Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16–20 Hours Reading Time
by: Gabriele Bianco, et al.
Published: (2022-10-01)